The antagonism of nondepolarizing neuromuscular blockade.
作者信息
Jenkins T E
出版信息
AANA J. 1980 Oct;48(5):452-60.
PMID:6449820
Abstract
The antagonism of the nondepolarizing neuromuscular blockade is accomplished many times in a given day. Fortunately, the incidents of complications are low. If they do occur and are not recognized and treated properly, however, the results can be serious. In this article, the author reviews the curariform group of drugs, anticholinesterases, and anticholinergics, evaluating the antagonism of the nondepolarizing neuromuscular blockade.
摘要
相似文献
1
The antagonism of nondepolarizing neuromuscular blockade.
AANA J. 1980 Oct;48(5):452-60.
2
New approaches to reversal of neuromuscular block.
Curr Opin Drug Discov Devel. 2002 Sep;5(5):793-800.
3
Muscle relaxants and reversal agents.
Crit Care Nurs Clin North Am. 1991 Mar;3(1):151-8.
4
Have we learned how to relax our patients, by thinking outside the box?
J Crit Care. 2009 Mar;24(1):1-4. doi: 10.1016/j.jcrc.2008.08.006. Epub 2009 Jan 17.
5
[Antagonists of neuromuscular blockade--mechanisms of action, adverse effects and dosages].
Klin Anasthesiol Intensivther. 1980;22:158-74.
6
Antagonism of non-depolarising neuromuscular block: current practice.
Anaesthesia. 2009 Mar;64 Suppl 1:22-30. doi: 10.1111/j.1365-2044.2008.05867.x.
7
Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent?
Anesthesiology. 2010 Jan;112(1):16-8. doi: 10.1097/ALN.0b013e3181c5388f.
8
Myths and facts in neuromuscular pharmacology. New developments in reversing neuromuscular blockade.
Minerva Anestesiol. 2012 Apr;78(4):473-82.
9
Preclinical pharmacology of sugammadex.
J Crit Care. 2009 Mar;24(1):29-35. doi: 10.1016/j.jcrc.2008.10.010.
10
Clinical limitations of acetylcholinesterase antagonists.
J Crit Care. 2009 Mar;24(1):21-8. doi: 10.1016/j.jcrc.2008.08.003. Epub 2009 Jan 17.
Zotero 插件